226 related articles for article (PubMed ID: 34358810)
1. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective.
Lobbes MBI; Heuts EM; Moossdorff M; van Nijnatten TJA
Eur J Radiol; 2021 Sep; 142():109883. PubMed ID: 34358810
[TBL] [Abstract][Full Text] [Related]
2. The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study.
Åhsberg K; Gardfjell A; Nimeus E; Ryden L; Zackrisson S
BMC Cancer; 2021 Oct; 21(1):1115. PubMed ID: 34663236
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
[TBL] [Abstract][Full Text] [Related]
4. The performance of contrast-enhanced mammography and breast MRI in local preoperative staging of invasive lobular breast cancer.
Lobbes MBI; Neeter LMFH; Raat F; Turk K; Wildberger JE; van Nijnatten TJA; Nelemans PJ
Eur J Radiol; 2023 Jul; 164():110881. PubMed ID: 37201248
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging.
Taylor DB; Burrows S; Saunders CM; Parizel PM; Ives A
Eur Radiol Exp; 2023 Feb; 7(1):8. PubMed ID: 36781808
[TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia.
Nicosia L; Rotili A; Pesapane F; Bozzini AC; Battaglia O; Pellegrino G; Fusco N; Porta FM; Frassoni S; Bagnardi V; Corso G; Sangalli C; Cassano E
Breast Cancer Res Treat; 2024 Jan; 203(1):135-143. PubMed ID: 37787819
[TBL] [Abstract][Full Text] [Related]
7. Added value of contrast-enhanced mammography (CEM) in staging of malignant breast lesions-a feasibility study.
Åhsberg K; Gardfjell A; Nimeus E; Rasmussen R; Behmer C; Zackrisson S; Ryden L
World J Surg Oncol; 2020 May; 18(1):100. PubMed ID: 32438917
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Clauser P; Baltzer PAT; Kapetas P; Hoernig M; Weber M; Leone F; Bernathova M; Helbich TH
J Magn Reson Imaging; 2020 Aug; 52(2):589-595. PubMed ID: 32061002
[TBL] [Abstract][Full Text] [Related]
9. Contrast-enhanced mammography in breast cancer screening.
Coffey K; Jochelson MS
Eur J Radiol; 2022 Nov; 156():110513. PubMed ID: 36108478
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced Mammography versus Contrast-enhanced Breast MRI: A Systematic Review and Meta-Analysis.
Pötsch N; Vatteroni G; Clauser P; Helbich TH; Baltzer PAT
Radiology; 2022 Oct; 305(1):94-103. PubMed ID: 36154284
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI).
Barra FR; Sobrinho AB; Barra RR; Magalhães MT; Aguiar LR; de Albuquerque GFL; Costa RP; Farage L; Pratesi R
Biomed Res Int; 2018; 2018():8531916. PubMed ID: 30533440
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced mammography and breast MRI in the diagnosis of breast cancer and detection of tumor size.
Tekinhatun M; Sabir N; Erdem E; Yilmaz S; Ufuk F
Turk J Med Sci; 2024; 54(1):249-261. PubMed ID: 38812642
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound.
Abe H; Schacht D; Kulkarni K; Shimauchi A; Yamaguchi K; Sennett CA; Jiang Y
Acad Radiol; 2013 Nov; 20(11):1399-404. PubMed ID: 24119352
[TBL] [Abstract][Full Text] [Related]
14. Preoperative evaluation of breast cancer: Contrast-enhanced mammography versus contrast-enhanced magnetic resonance imaging: A systematic review and meta-analysis.
Shahraki Z; Ghaffari M; Nakhaie Moghadam M; Parooie F; Salarzaei M
Breast Dis; 2022; 41(1):303-315. PubMed ID: 35754256
[TBL] [Abstract][Full Text] [Related]
15. Patient perspectives on repeated contrast-enhanced mammography and magnetic resonance during neoadjuvant chemotherapy of breast cancer.
Pires-Gonçalves L; Henriques Abreu M; Ferrão A; Guimarães Dos Santos A; Aguiar AT; Gouvêa M; Henrique R
Acta Radiol; 2023 May; 64(5):1816-1822. PubMed ID: 36575580
[TBL] [Abstract][Full Text] [Related]
16. Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening.
Lawson MB; Partridge SC; Hippe DS; Rahbar H; Lam DL; Lee CI; Lowry KP; Scheel JR; Parsian S; Li I; Biswas D; Bryant ML; Lee JM
Radiology; 2023 Aug; 308(2):e230576. PubMed ID: 37581498
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced mammography in the assessment of residual disease after neoadjuvant treatment.
Hogan MP; Horvat JV; Ross DS; Sevilimedu V; Jochelson MS; Kirstein LJ; Goldfarb SB; Comstock CE; Sung JS
Breast Cancer Res Treat; 2023 Apr; 198(2):349-359. PubMed ID: 36754936
[TBL] [Abstract][Full Text] [Related]
18. Is contrast-enhanced mammography (CEM) an alternative to MRI in assessing the response to primary systemic therapy of breast cancer?
Sunen I; Isabel Garcia Barrado A; Cruz Ciria S; Garcia Maroto J; Gros Bañeres B; Garcia Mur C
Eur J Radiol; 2024 Jan; 170():111270. PubMed ID: 38141263
[TBL] [Abstract][Full Text] [Related]
19. Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study.
Bernardi D; Vatteroni G; Acquaviva A; Valentini M; Sabatino V; Bolengo I; Pellegrini M; Fantò C; Trimboli RM
AJR Am J Roentgenol; 2022 Dec; 219(6):884-894. PubMed ID: 35731101
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
